Rexahn Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Rexahn Pharmaceuticals Inc
CIK #0001228627
EDGAR Form CIK 2011 - 2026
10-K [0001228627]
10-Q [0001228627]
3 [0001228627]
4 [0001228627]
5 [0001228627]
8-K [0001228627]
D [0001228627]
SC 13D [0001228627]
SC 13G [0001228627]
Form 13D/13G Filer Form 13D/13G Subject Filed
Caligan Partners LP Opus Genetics Inc [2026-05-15]
Adage Capital Management LP Opus Genetics Inc [2026-05-13]
Balyasny Asset Management LP Opus Genetics Inc [2026-02-17]
BIOS Fund III LP Opus Genetics Inc [2025-08-11]
Nantahala Capital Management LLC Opus Genetics Inc [2025-05-15]
Perceptive Advisors LLC Opus Genetics Inc [2025-03-31]
Foundation Fighting Blindness Retinal Degeneration Fund Opus Genetics Inc [2024-10-29]
Richmond Brothers Inc Ocuphire Pharma Inc [2022-05-17]
Apexian Pharmaceuticals Inc Ocuphire Pharma Inc [2021-03-26]
Sooch Mina Ocuphire Pharma Inc [2021-03-17]
Altium Capital Management LP Ocuphire Pharma Inc [2020-11-16]
Richmond Brothers Inc Ocuphire Pharma Inc [2020-11-16]
Empery Asset Management LP Ocuphire Pharma Inc [2020-11-12]
Armistice Capital LLC Rexahn Pharmaceuticals Inc [2020-08-10]
Armistice Capital LLC Rexahn Pharmaceuticals Inc [2019-02-05]
Anson Funds Management LP Rexahn Pharmaceuticals Inc [2018-10-29]
CVI Investments Inc Rexahn Pharmaceuticals Inc [2018-10-26]
Sabby Management LLC Rexahn Pharmaceuticals Inc [2016-02-29]
Empery Asset Management LP Rexahn Pharmaceuticals Inc [2015-11-10]
Sabby Management LLC Rexahn Pharmaceuticals Inc [2012-12-04]
Form 3/4/5 Subject 2011 - 2026
Foundation Fighting Blindness Inc
Foundation Fighting Blindness Retinal Degeneration Fund
Rexahn Pharmaceuticals Inc
Magrath George
Jayagopal Ashwath
Zaremba Rabourn Amy
Yerxa Benjamin R
Gagnon Robert E
Schachle Joseph K
Bennett Jean
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-03-16 Sell 24,438 $5.21 127,322
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-03-16 Sell 3,719 $5.25 19,525
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-03-16 Sell 2,816 $5.25 14,784
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-03-16 Sell 3,719 $5.12 19,041
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-02-12 Tax withheld 5,313 $3.39 18,011
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-22 Grant 250,000 $0.00
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-22 Grant 400,000 $0.00
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-22 Grant 86,500 $0.00
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-22 Grant 483,639 $0.00
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-22 Grant 400,000 $0.00
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-22 Grant 400,000 $0.00
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-18 Tax withheld 3,390 $2.10 7,119
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-10 Tax withheld 3,950 $1.93 7,624
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-06 Grant 67,000 $0.00
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-01 Grant 23,643
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-01 Grant 21,127
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-01 Grant 42,507
Rexahn Pharmaceuticals Inc IRD
Common Stock
2026-01-01 Grant 31,188
Rexahn Pharmaceuticals Inc IRD
Common Stock
2025-12-31 Grant 33,000 $0.00
Rexahn Pharmaceuticals Inc IRD
Common Stock
2025-12-29 Buy 81,000 $1.98 160,380
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com